ClinicalTrials.Veeva

Menu

Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns

Q

Queen Fabiola Children's University Hospital

Status

Completed

Conditions

Right Ventricular Outflow Tract Reconstruction
Congenital Heart Defect

Treatments

Procedure: right ventricular outflow tract reconstruction with contegra
Procedure: right ventricular outflow tract reconstruction with pulmonary homograft

Study type

Observational

Funder types

Other

Identifiers

NCT03348397
P2016/Cardio/RVOTtherapy

Details and patient eligibility

About

Pulmonary homografts are standard substitutes for right ventricular outflow tract reconstruction in congenital heart surgery. Unfortunately shortage and conduit failure secondary to early calcifications and shrinking are observed particularly for small sized conduits in younger patients. In neonates, Contegra® 12mm could be a valuable alternative, but conflicting evidence exists. This retrospective study compared the outcome of these two conduits in a newborn population.

Enrollment

53 patients

Sex

All

Ages

Under 30 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

neonatal patients who had a reconstruction of the right ventricular outflow tract with a pulmonary homograft or a Contegra between January 1992 and December 2014 at HUDERF

Exclusion criteria

NA

Trial design

53 participants in 2 patient groups

Contegra patients
Treatment:
Procedure: right ventricular outflow tract reconstruction with contegra
Pulmonary homograft patients
Treatment:
Procedure: right ventricular outflow tract reconstruction with pulmonary homograft

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems